pitchbook.com Open in urlscan Pro
34.110.234.203  Public Scan

Form analysis
1 forms found in the DOM

/profiles/search

<form action="/profiles/search" class="search-form search-form_focused float-right-XL align-right" role="search" __bizdiag="113" __biza="WJ__">
  <input type="text" name="q" value="" maxlength="200" aria-label="Search" class="search-form__input" placeholder="Search profile previews">
  <button type="submit" aria-label="Search button" role="button" class="btn-search search-form__submit"></button>
  <span data-btn-search-collapsed="" class="XL-0 d-block-XS icon-profile-close secondary-text search-form__close px-xl-10 py-xl-5"></span>
</form>

Text Content

 * Request a free trial Log in
 * Products
 * Solutions
 * Data
 * News & Analysis
 * About
 * Blog

Log in Request a free trial


CONVERGENT THERAPEUTICS



This is a profile preview from the PitchBook Platform.

Request a free trial
 * Overview
 * Timeline
 * Valuation & Funding
 * Cap Table
 * Comparisons
 * Competitors
 * Research & Analysis
 * Patents
 * Team
 * Board Members
 * Service Providers
 * Signals
 * Investors
 * Lead Partners on Deals
 * Acquisitions
 * Subsidiaries
 * Exits


CONVERGENT THERAPEUTICS OVERVIEW

Update this profile
 * Founded


 * 2020


 * Status


 * PRIVATE

 * Employees


 * 5


 * Latest Deal Type


 * SERIES A1

 * Latest Deal Amount


 * $90M

 * Investors


 * 3


CONVERGENT THERAPEUTICS GENERAL INFORMATION

Description

Operator of a clinical-stage biotechnology company intended to explore the full
potential of dual-targeted combination strategies to treat cancer. The company
has developed a therapeutic platform that is capable of targeting validated and
novel cancer antigens by leveraging targeting agents with different
bio-distributions, such as monoclonal antibodies, ligands and supra-additive
therapeutic doses, enabling medical professionals to provide effective cancer
treatment to its patients.

Contact Information

Website
www.convergentrx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
 * Cambridge, MA
 * United States

+1 (631) 000-0000




CONVERGENT THERAPEUTICS TIMELINE

202120222023
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth


WANT DETAILED DATA ON 3M+ COMPANIES?

What you see here scratches the surface

Request a free trial


WANT TO DIG INTO THIS PROFILE?

We’ll help you find what you need

Learn more


CONVERGENT THERAPEUTICS VALUATION & FUNDING

Deal Type Date Amount Raised to Date Post-Val Status Stage 3. Early Stage VC
(Series A1) 03-May-2023 $90M 0000 00000 Completed Pre-Clinical Trials 2. Early
Stage VC (Series A2) 08-Apr-2022 00.00 000 0000 Completed Pre-Clinical Trials 1.
Early Stage VC (Series A3) $5.5M $5.5M 000.00 Completed Pre-Clinical Trials

To view Convergent Therapeutics’s complete valuation and funding history,
request access »


CONVERGENT THERAPEUTICS CAP TABLE

Stock # of Shares
Authorized Par Value Dividend Rate (%) Original
Issue Price Liquidation Liquidation
Pref. Multiple Conversion Price % Owned Series A-1 00,000,000 00.000000 00 00.00
00.00 00 00.00 00.000 Series A-3 0,000,000 00.000000 00 00.00 00.00 00 00.00
0.000 Series A-2 2,801,467 $0.001000 6% $1.24 $1.24 1x $1.24 2.71%

To view Convergent Therapeutics’s complete cap table history, request access »


CONVERGENT THERAPEUTICS EXECUTIVE TEAM (3)

Update this profile

Name Title Board Seat Contact Info Alex Brown Chief Operating Officer Neil
Bander MD Co-Founder & Chief Scientific Advisor Philip Kantoff Co-Founder, Chief
Executive Officer and Chief Medical Officer

To view Convergent Therapeutics’s complete executive team members history,
request access »


CONVERGENT THERAPEUTICS SIGNALS

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth
using web presence and social reach.

Request a free trial



CONVERGENT THERAPEUTICS INVESTORS (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact
Info OrbiMed PE/Buyout Minority 000 0000 000000 0 RA Capital Management Hedge
Fund Minority 000 0000 000000 0 The Invus Group PE/Buyout Minority 000 0000
000000 0

To view Convergent Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial
Products
 * PitchBook Desktop
 * PitchBook Mobile
 * CRM Integration
 * Excel Plugin
 * Chrome Extension
 * Direct Data
 * Institutional Research Group
 * Morningstar Institutional Equity Research
 * Product Releases

PitchBook for

 * Private Market Valuations
 * Venture Capital
 * Private Equity
 * Hedge Funds
 * Startups

Profile Previews
Solutions
 * Private Market Intel
 * Fundraising
 * Deal Sourcing
 * Due Diligence
 * Business Development
 * Networking
 * Deal Execution
 * Benchmarking
 * Asset Allocation

Blog Webinars Video Library
Data
 * Companies
 * Investors
 * Deals
 * M&A
 * Limited Partners
 * Funds
 * Financials
 * Advisors
 * Professionals
 * Debt
 * Lenders
 * Data Operations

Leveraged Commentary and Data
News & analysis
 * Reports
 * Newsletter
 * Advertise
 * Research & Analysis Team

About
 * Customer Success
 * Client Testimonials
 * What Sets Us Apart
 * Press Inquiries
 * Partnerships
 * Careers

Follow us

 * 
 * 
 * 
 * 
 * 

US Headquarters

 * +1 (206) 623.1986
 * 901 Fifth Avenue
 * Suite 1200
 * Seattle, WA 98164

European Headquarters

 * +44 (0) 20 8037.2308
 * 1st Floor Saffron House
 * 6-10 Kirby Street
 * London EC1N 8TS
 * United Kingdom

Asia-Pacific Headquarters

 * 80 Raffles Place
 * #41-01 UOB Plaza 1
 * Singapore 048624

Contact Us
 * info@pitchbook.com
 * Request Research
 * Profile Request
 * Deal Submission
 * GDPR Compliance

Follow us

 * 
 * 
 * 
 * 
 * 

© 2023 PitchBook. Win what’s next. All rights reserved.

 * Terms of Use
 * Privacy Policy




We need your consent to proceed to PitchBook
Our site uses cookies and other technologies to improve your experience and
understand how you and other visitors use our site.
You can configure your preferences at any time using the cookie policy tool.
When you access our site, the companies listed in our cookie policy will use
cookies on our site.
Agree and Enter
Close  ✖